TY - JOUR
T1 - Recent molecular insights from mutated IKS channels in cardiac arrhythmia
AU - Dvir, Meidan
AU - Peretz, Asher
AU - Haitin, Yoni
AU - Attali, Bernard
N1 - Funding Information:
This work was supported by the Fields Fund for Cardiovascular Research , the Deutsch-Israelische Projektkooperation DIP fund ( DFG, AT119/1-1 ) and the Israel Science Foundation ( ISF 1215/13 ).
PY - 2014/4/1
Y1 - 2014/4/1
N2 - Co-assembly of KCNQ1 with KCNE1 generates the IKS potassium current that is vital for the proper repolarization of the cardiac action potential. Mutations in either KCNQ1 or KCNE1 genes lead to life-threatening cardiac arrhythmias causing long QT syndrome, short QT syndrome, sinus bradycardia and atrial fibrillation. Findings emerging from recent studies are beginning to provide a picture of how gain-of-function and loss-of-function mutations are associated with pleiotropic cardiac phenotypes in the clinics. In this review, we discuss recent molecular insights obtained from mutations altering different structural modules of the channel complex that are essential for proper IKS function. We present the possible molecular mechanisms underlying mutations impairing the voltage sensing functions, as well as those altering the channel regulation by phosphatidylinositol-4,5-bisphosphate, calmodulin and protein kinase A. We also discuss the significance of diseased IKS channels for adequate pharmacological targeting of cardiac arrhythmias.
AB - Co-assembly of KCNQ1 with KCNE1 generates the IKS potassium current that is vital for the proper repolarization of the cardiac action potential. Mutations in either KCNQ1 or KCNE1 genes lead to life-threatening cardiac arrhythmias causing long QT syndrome, short QT syndrome, sinus bradycardia and atrial fibrillation. Findings emerging from recent studies are beginning to provide a picture of how gain-of-function and loss-of-function mutations are associated with pleiotropic cardiac phenotypes in the clinics. In this review, we discuss recent molecular insights obtained from mutations altering different structural modules of the channel complex that are essential for proper IKS function. We present the possible molecular mechanisms underlying mutations impairing the voltage sensing functions, as well as those altering the channel regulation by phosphatidylinositol-4,5-bisphosphate, calmodulin and protein kinase A. We also discuss the significance of diseased IKS channels for adequate pharmacological targeting of cardiac arrhythmias.
UR - http://www.scopus.com/inward/record.url?scp=84891519746&partnerID=8YFLogxK
U2 - 10.1016/j.coph.2013.12.004
DO - 10.1016/j.coph.2013.12.004
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
AN - SCOPUS:84891519746
SN - 1471-4892
VL - 15
SP - 74
EP - 82
JO - Current Opinion in Pharmacology
JF - Current Opinion in Pharmacology
IS - 1
ER -